drug

tisagenlecleucel

1 story · latest Jul 2, 2026

Status: Investigational
Code: CTL019
Trials: 3 registered trials in coverage

Relationships

Developed by Novartis

Timeline

Novartis: Mayzent label update approved; four real-world studies registered or recruiting

Jul 2Weekly roundup, 7 itemsalpelisib Fludarabine

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.